AVIDITY BIOSCIENCES INC (RNA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RNA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RNA | President, Chief Executive Officer, and Director | 53 | [] | [] | 2025 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OABI | Director | 52 | ["President and Chief Executive Officer of Avidity Biosciences, Inc.","Director and President of Akcea Therapeutics","Chief Business Officer at Ionis Pharmaceuticals, Inc.","Vice President, Head of International Business Strategy and Operations at Forest Laboratories, Inc.","Experience with Alexion Pharmaceuticals Inc., Novartis Group AG, Bayer AG, and F. Hoffmann-La Roche AG","Board member at Berkeley Lights Inc."] | ["Human Capital Management & Compensation (Chair)"] | 2024 |
| LGND | President and CEO of Avidity Biosciences, Inc. | 50 | [] | [] | 2022 |